Rubric Capital Management LP Day One Biopharmaceuticals, Inc. Transaction History
Rubric Capital Management LP
- $6.08 Billion
- Q3 2025
A detailed history of Rubric Capital Management LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 3,377,071 shares of DAWN stock, worth $29.7 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
3,377,071Holding current value
$29.7 Million% of portfolio
0.39%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
180Shares Held
70.6MCall Options Held
42.8KPut Options Held
60.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$56.6 Million10.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$54.4 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4.71MShares$41.4 Million0.62% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$39.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.48MShares$30.6 Million0.01% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $646M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...